News - ViroPharma

Filter

Current filters:

ViroPharma

Popular Filters

Shire’s acquisition of ViroPharma will add $831m in revenue by 2018, says GlobalData

Shire’s acquisition of ViroPharma will add $831m in revenue by 2018, says GlobalData

19-11-2013

Ireland-based drugmaker Shire’s (LSE: SHP) buy-out of US orphan drug company ViroPharma (Nasdaq: VPHM)…

CinryzeEuropeFinancialMergers & AcquisitionsPharmaceuticalShireUSAViroPharma

Shire strengthens position in rare diseases with $4.2 billion buy of ViroPharma

Shire strengthens position in rare diseases with $4.2 billion buy of ViroPharma

11-11-2013

Ireland-based drugmaker Shire saw its share rise 2.2% to £33.16 shortly after markets opened this morning,…

CinryzeFirazyrMergers & AcquisitionsPharmaceuticalRare diseasesShireViroPharma

Stagnant treatment future seen for inherited orphan blood diseases

23-01-2013

Generally unimpressive treatment line-ups combined with weak product pipelines will lead to modest growth…

CinryzeMarkets & MarketingPharmaceuticalRare diseasesViroPharma

Initial PERFECT Initiative findings highlight problems with epilepsy treatment

01-10-2012

Children suffering from prolonged, acute, convulsive seizures may not always receive timely rescue medication…

EuropeHealthcareNeurologicalPharmaceuticalViroPharma

ViroPharma gets FDA backing for industrial scale Cinryze manufacturing

07-08-2012

US biotech firm ViroPharma (Nasdaq: VPHM) says that the US Food and Drug Administration has approved…

BiotechnologyCinryzeNorth AmericaProductionRegulationReproductiveViroPharma

ViroPharma buys option to acquire Meritage Pharma

28-12-2011

ViroPharma (Nasdaq: VPHM) has entered into an exclusive option to acquire fellow USA based Meritage Pharma,…

BudesonideMergers & AcquisitionsMeritage PharmaPharmaceuticalRare diseasesResearchViroPharma

ViroPharma to acquire DuoCort Pharma for up to $164 million, adding European orphan drug to pipeline

28-10-2011

The USA’s ViroPharma (Nasdaq: VPHM) says it has signed a definitive agreement to acquire DuoCort…

DuoCort PharmaMergers & AcquisitionsPharmaceuticalPlenadrenRare diseasesViroPharma

Intellect Neurosciences grants ViroPharma a license to OX1 in $126.5 million deal

03-10-2011

USA-based Intellect Neurosciences (OTCBB: ILNS.PK) has granted an exclusive license to US biotech firm…

BiotechnologyIntellect NeuroscienceLicensingPharmaceuticalRare diseasesViroPharma

ViroPharma's Buccolam gets EU approval for treatment of pediatric acute seizures

07-09-2011

USA-based ViroPharma (Nasdaq: VPHM) said yesterday that the European Commission has granted a Centralized…

BuccolamEuropeNeurologicalPharmaceuticalRegulationViroPharma

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top